[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334255-105":59,"doc-detail-334255-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expression-of-mtor-cd163-sma-foxp3-as-survival-predictors-and-its-significance-in-patients-with-oral-squamous-cell-carcinoma","Expression of mTOR, CD163, α-SMA, FOXp3 as survival predictors and its significance in patients with oral squamous cell carcinoma","","Background Oral squamous cell carcinoma (OSCC), a major head and neck cancer, arises from squamous cells and is driven by multiple internal and external factors. The PI3K/AKT/mTOR pathway is frequently mutated in head and neck cancers, while the tumor microenvironment—composed largely of immune cells—shapes progression. Methods examined 260 retrospective samples using immunohistochemistry for mTOR, α-SMA, CD163, and FOXp3, with survival analyzed by Kaplan-Meier. Results evaluated marker expression alone and in combinations against clinicopathological parameters.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-of-mtor-cd163-sma-foxp3-as-survival-predictors-and-its-significance-in-patients-with-oral-squamous-cell-carcinoma/334255/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-of-mtor-cd163-sma-foxp3-as-survival-predictors-and-its-significance-in-patients-with-oral-squamous-cell-carcinoma/334255.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which biomarkers were evaluated as survival predictors in OSCC?","Question",{"text":112,"@type":113},"The study assessed mTOR, CD163, α-SMA, and FOXp3 using immunohistochemistry and compared their expression with survival outcomes in OSCC patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were survival outcomes analyzed?",{"text":117,"@type":113},"Survival outcomes were calculated using the Kaplan-Meier statistical method.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about marker expression combinations and prognosis?",{"text":121,"@type":113},"Higher combined expression of all four markers was associated with poor prognosis, while lower expression correlated with better outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334255,1790012799,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Ramalingam etal. BMCOral Health (2024) 24:1487 [https://doi.org/10.1186/s12903-024-05245-y](https://doi.org/10.1186/s12903-024-05245-y)  \nBMC Oral Health  \n RESEARCH Open Access  \nExpression of mTOR, CD163, α-SMA, FOXp3   as survival predictors and its significance in patients with oral squamous cell carcinoma  \nSuganya Ramalingam1, Sivaramakrishnan Shantha1, Chakravarthy Purushothaman Srinivasan 1, Nagarajan Priyathersini2, Susruthan Muralitharan3, Uma Sudhakar4, HarikrishnanThamizhchelvan1* and Venkatachalam Deepa Parvathi5*  \nAbstract  \nBackground Oral cancer; categorised under head and neck cancers (HNC) predominantly originates from squamous cells and is referred as oral squamous cell carcinoma (OSCC) . Various factors (internal and external) causes OSCC. PI3K/ AKT/mTOR pathways are known to be primarily mutated in HNC. mTOR remains as a key regulator for various physiological and developmental processes in normal and cancer cells. Cancer cells are surrounded by tumor microenvironment, majorly composed of immune cells. Cancer associated fibroblasts, macrophages and regulatory T cells controlled by mTOR, plays an important role in the progression of cancer.  \nMethods Two hundred sixty retrospective patient samples were collected along with their demographical and clinicpathological data. Here, we have analysed expression of mTOR, α-SMA, CD163 and FOXp3 using immunohistochemistry and their survival outcomes were calculated using Kaplan-Meier statistical method.  \nResults Overexpression of CD163 and α-SMA was detected in samples of patients compared to mTOR and FOXp3 . Their expression was compared with clinico-oncological parameters. We also observed two and three combinations of markers and its association with the prognosis of the cancer. The results suggest, higher the expression of all the four markers in combination correlated to poor prognosis of patients and vice-versa.  \nConclusion The study reveals that over expression of CD163 and α-SMA is strongly associated with disease outcome. The combinations of all the four marker expression profile will be emerging strategy towards prognosis and also to determine survival outcomes in patients. This is a pioneering observation of these combinations of markers in OSCC despite certain limitations.  \nKeywords Immunohistochemical Markers, Kaplan-Meier, Prognosis, Head and Neck cancer, Retrospective  \n*Correspondence:  \nHarikrishnanThamizhchelvan [hod.oralpathology@sriramachandra.edu.in](hod.oralpathology@sriramachandra.edu.in)[ ](hod.oralpathology@sriramachandra.edu.in)Venkatachalam Deepa Parvathi  \n[deepaparvathi@sriramachandra.edu.in](deepaparvathi@sriramachandra.edu.in); [deepakoushik305@gmail.com](deepakoushik305@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nRamalingam etal. BMCOral Health (2024) 24:148","cbCaibcM3TpFtJBW","https://ap.wps.com/l/cbCaibcM3TpFtJBW","pdf",6763462,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Which biomarkers were evaluated as survival predictors in OSCC?\",\"answer\":\"The study assessed mTOR, CD163, α-SMA, and FOXp3 using immunohistochemistry and compared their expression with survival outcomes in OSCC patients.\"},{\"question\":\"How were survival outcomes analyzed?\",\"answer\":\"Survival outcomes were calculated using the Kaplan-Meier statistical method.\"},{\"question\":\"What did the study find about marker expression combinations and prognosis?\",\"answer\":\"Higher combined expression of all four markers was associated with poor prognosis, while lower expression correlated with better outcomes.\"}]","Expression of mTOR, CD163, α-SMA, FOXp3 as survival predictors and its significance in patients with oral squamous cell carcinoma | PDF",1790005999]